Skip to main navigation Skip to search Skip to main content

Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

  • The COMPASS Consortium
  • , The INVENT Consortium
  • , The Dutch Parelsnoer Initiative (PSI) Cerebrovascular Disease Study Group
  • , The Estonian Biobank
  • , The PRECISE4Q Consortium
  • , The FinnGen Consortium
  • , The NINDS Stroke Genetics Network (SiGN)
  • , The MEGASTROKE Consortium
  • , The SIREN Consortium
  • , The China Kadoorie Biobank Collaborative Group
  • , The VA Million Veteran Program
  • , The International Stroke Genetics Consortium (ISGC)
  • , The Biobank Japan
  • , the CHARGE consortium
  • , The GIGASTROKE Consortium
  • , Regeneron Genetics Center
  • , The ODYSSEY Study
  • , HUNT All-In Stroke
  • , The SICFAIL Study
  • , The Generacion Study
    • The Copenhagen City Heart Study, The SMART Study, Clinical Research Collaboration for Stroke in Korea (CRCS-K) and Korea Biobank Array (KBA) Project, Helsinki Stroke Project, Follow-up Studies, EPIC-CVD

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Fingerprint

Dive into the research topics of 'Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)'. Together they form a unique fingerprint.
Sort by

INIS

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry